Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · BILL · 115th Congress · H.R. 6 (EAH) — 115 HR 6 EAH: SUPPORT for Patients and Communities Act · Sec. 3012

Sec. 3012. Notification, nondistribution, and recall of controlled substances

675 words·~3 min read·/bill/115/hr/6/eah/section-3012

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 301 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 331 ) is amended by adding at the end the following: The failure to comply with any order issued under section 569D. . Subchapter E of chapter V of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb et seq.) is amended by adding at the end the following: If the Secretary determines there is a reasonable probability that a controlled substance would cause serious adverse health consequences or death, the Secretary may, after providing the appropriate person with an opportunity to consult with the agency, issue an order requiring manufacturers, importers, distributors, or pharmacists, who distribute such controlled substance to immediately cease distribution of such controlled substance.
An order under paragraph
(1)shall provide the person subject to the order with an opportunity for an informal hearing, to be held not later than 10 days after the date of issuance of the order, on whether adequate evidence exists to justify an amendment to the order, and what actions are required by such amended order pursuant to subparagraph (3). After an order is issued according to the process under paragraphs
(1)and (2), the Secretary shall, except as provided in paragraph (4)— vacate the order, if the Secretary determines that inadequate grounds exist to support the actions required by the order; continue the order ceasing distribution of the controlled substance until a date specified in such order; or amend the order to require a recall of the controlled substance, including any requirements to notify appropriate persons, a timetable for the recall to occur, and a schedule for updates to be provided to the Secretary regarding such recall. If the Secretary determines that the risk of recalling a controlled substance presents a greater health risk than the health risk of not recalling such controlled substance from use, an amended order under subparagraph
(B)or
(C)of paragraph
(3)shall not include either a recall order for, or an order to cease distribution of, such controlled substance, as applicable. Any person who is subject to an order pursuant to subparagraph
(B)or
(C)of paragraph
(3)shall immediately cease distribution of or recall, as applicable, the controlled substance and provide notification as required by such order. If the Secretary determines necessary, the Secretary may require the person subject to an order pursuant to paragraph
(1)or an amended order pursuant to subparagraph
(B)or
(C)of paragraph
(3)to provide either a notice of a recall order for, or an order to cease distribution of, such controlled substance, as applicable, under this section to appropriate persons, including persons who manufacture, distribute, import, or offer for sale such product that is the subject of an order and to the public. In providing such notice, the Secretary may use the assistance of health professionals who prescribed or dispensed such controlled substances. An order described in subsection (a)(3) shall be ordered by the Secretary or an official designated by the Secretary. An official may not be so designated under this section unless the official is the Director of the Center for Drug Evaluation and Research or an official senior to such Director. Nothing contained in this section shall be construed as limiting— the authority of the Secretary to issue an order to cease distribution of, or to recall, any drug under any other provision of this Act or the Public Health Service Act; or the ability of the Secretary to request any person to perform a voluntary activity related to any drug subject to this Act or the Public Health Service Act. . The third sentence of section 801(a) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 381(a) ) is amended by inserting , or is a controlled substance subject to an order under section 569D before , or
(4). Sections 301(eee) and 569D of the Federal Food, Drug, and Cosmetic Act, as added by subsections
(a)and (b), shall be effective beginning on the date of enactment of this Act.
Connectionstraces to 3
Citation graph
cites case law
Sec. 3012
Notification, nondistribution, and recall of controlled substances
Cites 3Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.